Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils von Neuhoff

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Orphanet Journal of Rare Diseases|May 25, 2012
Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiencyA-Rembert Koczulla, Danny Jonigk, Thomas Wolf, et al.
British Journal of Haematology|November 28, 2008
Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL geneEl-Harith Abdelghaffar El-Harith, Cornelia Roesl, Matthias Ballmaier, et al.
Human Gene Therapy|November 25, 2010
Genetically modified donor leukocyte transfusion and graft-versus-leukemia effect after allogeneic stem cell transplantationSylvia Borchers, Elena Provasi, Anna Silvani, et al.
Blood|February 17, 2005
Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesisUte Modlich, Olga S Kustikova, Manfred Schmidt, et al.
British Journal of Haematology|March 17, 2020
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemiaKristian Løvvik Juul-Dam, Hans B Ommen, Charlotte G Nyvold, et al.
Cancers|March 6, 2021
Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study GroupMareike Rasche, Emma Steidel, Martin Zimmermann, et al.
Clinical and Translational Medicine|November 2, 2022
Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotypeLea Jessica Albrecht, Anna Höwner, Klaus Griewank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2024
Influence of Nucleophosmin (<i>NPM1</i>) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup CollaborationClaudia Tregnago, Maddalena Benetton, Rhonda E Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapseStephanie Ehlers, Christin Herbst, Martin Zimmermann, et al.
Eclinicalmedicine|June 16, 2025
No evidence of leukaemia (NEL) as a response criteria in paediatric AML: a multicentre analysisEvangelia Antoniou, Annika Puschnig, Naghmeh Niktoreh, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Orphanet Journal of Rare Diseases|May 25, 2012
Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiencyA-Rembert Koczulla, Danny Jonigk, Thomas Wolf, et al.
British Journal of Haematology|November 28, 2008
Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL geneEl-Harith Abdelghaffar El-Harith, Cornelia Roesl, Matthias Ballmaier, et al.
Human Gene Therapy|November 25, 2010
Genetically modified donor leukocyte transfusion and graft-versus-leukemia effect after allogeneic stem cell transplantationSylvia Borchers, Elena Provasi, Anna Silvani, et al.
Blood|February 17, 2005
Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesisUte Modlich, Olga S Kustikova, Manfred Schmidt, et al.
British Journal of Haematology|March 17, 2020
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemiaKristian Løvvik Juul-Dam, Hans B Ommen, Charlotte G Nyvold, et al.
Cancers|March 6, 2021
Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study GroupMareike Rasche, Emma Steidel, Martin Zimmermann, et al.
Clinical and Translational Medicine|November 2, 2022
Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotypeLea Jessica Albrecht, Anna Höwner, Klaus Griewank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2024
Influence of Nucleophosmin (<i>NPM1</i>) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup CollaborationClaudia Tregnago, Maddalena Benetton, Rhonda E Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapseStephanie Ehlers, Christin Herbst, Martin Zimmermann, et al.
Eclinicalmedicine|June 16, 2025
No evidence of leukaemia (NEL) as a response criteria in paediatric AML: a multicentre analysisEvangelia Antoniou, Annika Puschnig, Naghmeh Niktoreh, et al.
Pageof 7